SRP100261 PRJNA375869 GSE95059 Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone Normal human cardiac fibroblast were treated with 200 nM halofuginone for 24 hours and the transcriptomic profile was measured by RNAseq. Overall design: Total of 6 samples analyzed, 3 treated with vehicle and 3 treated with halofuginone. GSE95059 pubmed 28487390